Prime Therapeutics welcomes new client success leader
DeZearn to lead our client teams and help ensure Prime’s client relationships are collaborative, accountable, responsive and aligned
April 26, 2021
As vice president of client success, DeZearn is responsible for leading our client teams and helping to ensure Prime’s client relationships are collaborative, accountable, responsive and aligned. DeZearn is a licensed clinical pharmacist and has extensive pharmacy benefit management industry experience with sales and account management.
In her nearly 30-year career, DeZearn has led clinical and sales/account management teams at Diversified Pharmaceutical Services, Merck-Medco Managed Care, Medco Health Solutions, Anthem and most recently, Express Scripts. She has led initiatives in benefit design, clinical and formulary management aimed at lowering overall drug costs.
“Karen is a team-oriented, metric driven leader who possesses the skills needed for Prime to continue to evolve its client relationships to be more strategic and mutually beneficial,” said Dave Schlett, chief financial officer.
DeZearn holds a Doctor of Pharmacy degree from Campbell University School of Pharmacy in North Carolina.
October 14, 2021
In first of its kind study, Prime Therapeutics explores paroxysmal nocturnal hemoglobinuria (PNH) C5 inhibitor treatment rates
EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) used its…
October 6, 2021
Prime Therapeutics launches new MedsYourWay™ offering, now giving Blue Plan members home delivery prescription option using Amazon Pharmacy
EAGAN, Minn. – Prime Therapeutics LLC, a leading pharmacy benefit manager, announces its…
September 29, 2021
Prime Therapeutics and Pear Therapeutics announce first comprehensive value-based agreement for prescription digital therapeutics reSET® and reSET-O® for the treatment of substance and opioid use disorders
BOSTON and EAGAN, Minn. – More than 20 million Americans struggle with drug…